CMB 1.20% 42.0¢ cambium bio limited

Bang, bang.From inflammation to pain treatment, RGS, through its...

  1. 172 Posts.
    lightbulb Created with Sketch. 52
    Bang, bang.
    From inflammation to pain treatment, RGS, through its Progenza platform, now holds multiple patents in Japan for the use of Mesenchymal Stem Cells.
    Then, Sygenus will be added, for the use of stem cells secretions.
    Very good news. This will only strengthen Kyocera's commercial position in the Japanese market.
 
watchlist Created with Sketch. Add CMB (ASX) to my watchlist
(20min delay)
Last
42.0¢
Change
0.005(1.20%)
Mkt cap ! $5.011M
Open High Low Value Volume
41.5¢ 42.0¢ 41.5¢ $898 2.162K

Buyers (Bids)

No. Vol. Price($)
1 2854 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
42.0¢ 4112 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
CMB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.